Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement
References
- Søndergaard Lars. Early Versus Later Re-valving in Tetralogy of Fallot with Free Pulmonary Regurgitation. 2019 May;(5th Edition). Available from: https://www.clinicaltrials.gov/ProvidedDocs/32/NCT04084132/Prot_SAP_000.pdf
- Westhoff-Bleck M, Kornau F, Haghikia A, Horke A, Bertram H, Treptau J, et al. NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation. Can J Cardiol. 2016 Oct;32(10):1247.e29-1247.e36.
- Villafañe J, Feinstein JA, Jenkins KJ, Vincent RN, Walsh EP, Dubin AM, et al. Hot Topics in Tetralogy of Fallot. J Am Coll Cardiol. 2013 Dec;62(23):2155–66.
- Downing TE, Kim YY. Tetralogy of Fallot. Cardiol Clin. 2015 Nov;33(4):531–41.
- Bhagra CJ, Hickey EJ, Van De Bruaene A, Roche SL, Horlick EM, Wald RM. Pulmonary Valve Procedures Late After Repair of Tetralogy of Fallot: Current Perspectives and Contemporary Approaches to Management. Can J Cardiol. 2017 Sep;33(9):1138–49.
- Heng EL. Improved outcome prediction in tetralogy of Fallot. 2016 Dec [cited 2022 Jul 12]; Available from: http://spiral.imperial.ac.uk/handle/10044/1/50676
- Zegelbone PM, Ringel RE, Coulson JD, Nies MK, Stabler ME, Brown JR, et al. Heart failure biomarker levels correlate with invasive haemodynamics in pulmonary valve replacement. Cardiol Young. 2020 Jan;30(1):50–4.
- van der Ven JPG, van den Bosch E, Bogers AJCC, Helbing WA. Current outcomes and treatment of tetralogy of Fallot. F1000Research. 2019;8:F1000 Faculty Rev-1530.
- Nawaytou H, Bernstein HS. Biomarkers in pediatric heart disease. Biomark Med. 2014 Aug;8(7):943–63.
- Peng EWK, Spooner R, Young D, Danton MHD. Acute B-type natriuretic peptide response and early postoperative right ventricular physiology following tetralogy of Fallot’s repair. Interact Cardiovasc Thorac Surg. 2012 Sep 1;15(3):335–9.
- Eindhoven JA, van den Bosch AE, Jansen PR, Boersma E, Roos-Hesselink JW. The Usefulness of Brain Natriuretic Peptide in Complex Congenital Heart Disease. J Am Coll Cardiol. 2012 Nov;60(21):2140–9.
- Jabagi H, Mielniczuk LM, Liu PP, Ruel M, Sun LY. Biomarkers in the Diagnosis, Management, and Prognostication of Perioperative Right Ventricular Failure in Cardiac Surgery—Are We There Yet? J Clin Med. 2019 Apr 25;8(4):559.
- Cantinotti M, Law Y, Vittorini S, Crocetti M, Marco M, Murzi B, et al. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev. 2014 Nov;19(6):727–42.
- Cantinotti M, Walters HL, Crocetti M, Marotta M, Murzi B, Clerico A. BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? Cardiol Young. 2015 Mar;25(3):424–37.
- S.E. Luijnenburg. Outcome Late After Repair of Tetralogy of Fallot [Internet]. Available from: https://repub.eur.nl/pub/40677/
- Dobson R, Walker HA, Walker NL. Biomarkers in congenital heart disease. Biomark Med. 2014 Aug;8(7):965–75.
- Willinger L, Brudy L, Meyer M, Oberhoffer-Fritz R, Ewert P, Müller J. Prognostic value of non-acute high sensitive troponin-T for cardiovascular morbidity and mortality in adults with congenital heart disease: A systematic review. J Cardiol. 2021 Sep;78(3):206–12.
- Hirono K, Sekine M, Shiba N, Hayashi S, Nakaoka H, Ibuki K, et al. N-terminal pro-Brain Natriuretic Peptide as a Predictor of Reoperation in Children With Surgically Corrected Tetralogy of Fallot. Circ J. 2014;78(3):693–700.
- Nir A, Luchner A, Rein AJ. The natriuretic peptides as biomarkers for adults with congenital heart disease. Biomark Med. 2012 Dec;6(6):827–37.
- Heng EL, Bolger AP, Kempny A, Davlouros PA, Davidson S, Swan L, et al. Neurohormonal activation and its relation to outcomes late after repair of tetralogy of Fallot. Heart. 2015 Mar 15;101(6):447–54.
- Paolino A, Hussain T, Pavon A, Velasco MN, Uribe S, Ordoñez A, et al. NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study. Pediatr Cardiol. 2017 Feb;38(2):324–31.
- Eindhoven JA, Menting ME, van den Bosch AE, Cuypers JAAE, Ruys TPE, Witsenburg M, et al. Associations between N-terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot. Int J Cardiol. 2014 Jul;174(3):550–6.
- Schoonbeek RC, Pieper PG, van Slooten YJ, Freling HG, Sieswerda GT, van Dijk APJ, et al. NT-proBNP and exercise capacity in adult patients with congenital heart disease and a prosthetic valve: a multicentre PROSTAVA study. Neth Heart J. 2016 Nov;24(11):653–65.
- Baggen VJM, van den Bosch AE, Eindhoven JA, Schut ARW, Cuypers JAAE, Witsenburg M, et al. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease. Circulation. 2017 Jan 17;135(3):264–79.
- Rajpal S, Alshawabkeh L, Opotowsky AR. Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease. Curr Cardiol Rep. 2017 Jun;19(6):50.
- Yasukawa T, Hoashi T, Imai K, Okuda N, Fukuda T, Ohuchi H, et al. The reduced left ventricular stroke volume does not fully recover after pulmonary valve replacement in patients with repaired tetralogy of Fallot. Eur J Cardiothorac Surg. 2021 Sep 11;60(3):526–33.
- Kitagawa A, Oka N, Kimura S, Ando H, Honda T, Takanashi M, et al. Clinical Utility of the Plasma Brain Natriuretic Peptide Level in Monitoring Tetralogy of Fallot Patients over the Long Term After Initial Intracardiac Repair: Considerations for Pulmonary Valve Replacement. Pediatr Cardiol. 2015 Apr;36(4):752–8.
- Kapoor PM, Subramanian A, Malik V, Kiran U, Velayoudham D. B-type natriuretic peptide as prognostic marker in tetralogy of Fallot surgery. Asian Cardiovasc Thorac Ann. 2015 Feb;23(2):146–52.
- Khokhar A, Zuhair M, Raj B, Heng EL, Alonso-Gonzalez R, Kempny A, et al. 2109Predictors of mortality following hospitalisation in adults with congenital heart disease. Eur Heart J [Internet]. 2018 Aug 1 [cited 2022 Aug 26];39(suppl_1). Available from: https://academic.oup.com/eurheartj/article/doi/10.1093/eurheartj/ehy565.2109/5082713
- Alborikan S, Von Klemperer K, Bhan A, Walker F, Pandya B, Badiani S, et al. Blood biomarkers in patients with repaired Tetralogy of Fallot (rTOF); A systematic review and meta-analysis. Int J Cardiol Congenit Heart Dis. 2021 Dec;6:100237.
Language: English
Page range: 11 - 16
Submitted on: Oct 20, 2022
Accepted on: Feb 14, 2023
Published on: Mar 29, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2023 Milla Marika Kainlauri, Irina-Bianca Kosovski, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.